Rentokil Initial (LON:RTO – Free Report) had its target price lowered by Royal Bank Of Canada from GBX 540 to GBX 480 in a report issued on Thursday morning,London Stock Exchange reports. The brokerage currently has an outperform rating on the stock.
RTO has been the topic of a number of other research reports. Citigroup dropped their price objective on Rentokil Initial from GBX 575 to GBX 550 and set a “buy” rating on the stock in a research note on Friday. Jefferies Financial Group reissued a “buy” rating and issued a GBX 550 target price on shares of Rentokil Initial in a research note on Thursday, July 9th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of GBX 468.33.
Check Out Our Latest Research Report on Rentokil Initial
Rentokil Initial Stock Down 0.5%
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Further Reading
- Five stocks we like better than Rentokil Initial
- Peeling Out or Breaking Down? Ford’s High-Stakes Turnaround
- Generac’s AI Power Story Is Becoming Bigger Than the Weather
- Everyone’s Focused on China—But That’s Not ASML’s Biggest Risk
- Chipotle Mexican Grill Stock Rallies as Q2 Results Top Fears, Guidance Rises
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
